Why Am I Not Losing Weight on GLP-1? 10 Evidence-Based Reasons

Updated on
Why Am I Not Losing Weight on GLP-1? 10 Evidence-Based Reasons

 

✓ Medically Verified
PG
✍️ Written by
Dr. Prakrati Garg
Research Associate, Shoolini University · Content Strategist, Karespot
SU
🧬 Medically Reviewed by
Dr. Sana Umar
Assistant Professor, Doon Medical College · FRCP · NMC Registered · Medical Reviewer, Karespot
Written July 2026
Reviewed July 2026
Updated July 2026
Read time 12 min
📉 Weight-Loss Plateaus & GLP-1 · Kare Hub

Is It Normal to Stop Losing Weight on Semaglutide? Understanding Weight-Loss Plateaus

Yes — and the clinical trials show almost exactly when it should happen. In STEP-1, semaglutide weight loss reached its nadir at week 60. In STEP-4, it plateaued between weeks 60 and 68 even on continued treatment. A plateau is not the drug failing. It is the curve the drug produces. [1, 2]

⚡ Key Takeaways
1
A plateau is expected, not a malfunction — STEP-1 weight loss hit its nadir at week 60; STEP-4 plateaued at weeks 60–68 on continued treatment. [1, 2]
2
Metabolic adaptation is the main driver — a lighter body burns fewer calories, so the deficit that drove your results quietly shrinks as you succeed.
3
Muscle loss deepens the plateau — and is preventable — lean soft tissue has accounted for roughly 26–40% of weight lost in GLP-1 trials, lowering resting metabolic rate. [3]
4
The scale lies in the short term — hydration, sodium, hormones and bowel habits mask real fat loss for weeks at a time. [4]
5
A plateau is a signal to review — not to quit — stopping treatment led to regain of about two-thirds of lost weight within a year. [5]
6
Personalised clinical review finds the cause — Karespot's Internal Medicine specialists and Endocrinologists assess dose, protein, training, sleep and metabolic health before changing anything.
Check your eligibility →

Is It Normal to Stop Losing Weight on Semaglutide?

⚡ Direct Answer

Yes. A temporary weight-loss plateau on semaglutide is normal and expected. Clinical trial data show weight loss is steepest in the first several months and then flattens as the body adapts to a lower weight — in STEP-1, weight loss reached its nadir at week 60, and in STEP-4 it plateaued between weeks 60 and 68 even with continued treatment. A plateau does not mean the medication has stopped working.

"In the semaglutide group, weight loss was observed from the first postrandomization assessment (week 4) onward, reaching a nadir at week 60."

Wilding JPH et al. N Engl J Med. 2021 — the STEP-1 trial, 1,961 participants. [1]

This is worth sitting with, because it reframes the anxiety most people feel. The flattening of the curve is not a failure of the drug — it is the curve the drug produces.

📊 STEP-4: What Happens When You Continue vs Stop
803 adults · all on semaglutide 2.4 mg for a 20-week run-in, then randomised to continue or switch to placebo
0% −5% −10% −15% −20% 0 20 28 36 44 52 60 68 Weeks of treatment 20-wk run-in (all on semaglutide) ↓ Randomised Plateau · weeks 60–68 Continued −17.4% Stopped −5.0%

Run-in (everyone)

Continued semaglutide

Switched to placebo

Schematic representation of the reported trajectories. Endpoint values are as published: continued semaglutide reached −17.4% overall and plateaued at weeks 60–68; participants switched to placebo regained 6.9 percentage points, ending at −5.0%. Source: Rubino D et al., JAMA. 2021. [2]

Read the two lines carefully, because they answer the question people are really asking. Participants who stayed on semaglutide kept losing, then settled into a plateau — the green line flattens. Participants who stopped steadily regained — the amber line climbs. The plateau, in other words, is the destination. And staying on treatment is what holds it there. [2]

🔍 Karespot Clinical Insight

Holding a 15% weight reduction against a body that is metabolically pushing to regain it is a real physiological achievement — even though the scale looks static. Maintenance is active work, not passive stalling.

Why Does a Weight-Loss Plateau Happen on Semaglutide?

⚡ Direct Answer

A plateau happens because your energy balance re-equalises. As you lose weight, your body needs fewer calories to function (metabolic adaptation), you may lose metabolically active muscle alongside fat, appetite may partially reassert itself, and small increases in intake or drops in activity accumulate. Together these erode the calorie deficit that produced your earlier results.

The mechanism most plateau articles miss: muscle

Across recent GLP-1 trials, lean soft tissue loss has comprised roughly 26–40% of total weight lost. Muscle burns more calories at rest than fat does — so every kilogram of muscle you shed lowers your resting metabolic rate and makes the next kilogram of fat harder to lose. A plateau is, in part, self-inflicted muscle loss catching up with you. [3, 6]

🧬 The GLP-1 paradox

Semaglutide works by reducing appetite — which makes it structurally harder to eat enough protein. The very mechanism that drives your weight loss is the one that puts your muscle at risk. Set a target with the Karespot Protein Calculator and see our macro ratio guide.

The seven contributors, ranked

How Long Does a Semaglutide Plateau Last?

⚡ Direct Answer

There is no fixed duration. Plateaus of two to four weeks are extremely common and usually resolve on their own. A plateau lasting longer than about eight to twelve weeks, particularly once you have reached the 2.4 mg maintenance dose, is worth reviewing with your doctor — not because the medication has failed, but because a modifiable cause can often be identified.

Crucially, not all plateaus mean the same thing. Where you are in treatment changes the diagnosis entirely:

Your situation Most likely explanation What to do
Flat at week 6–10
Still titrating 		You have not reached a therapeutic dose. 0.25 mg and 0.5 mg are adaptation doses, not treatment doses. [8] Patience. Continue the escalation schedule as prescribed. Build protein and training habits now.
Flat for 2–4 weeks
Any stage 		Routine fluctuation. Water, sodium, hormones and bowel habits easily mask 4 weeks of fat loss. [4] Nothing. Judge the trend over 4–6 weeks. Check waist, not just weight.
Flat 8–12+ weeks on 2.4 mg
Maintenance dose 		Deficit has likely closed — via metabolic adaptation, lean-mass loss, or lifestyle drift. Occasionally an untreated condition. Book a medical review. Do not self-escalate. [9]
Stable at 12–15 months
Long-term treatment 		You have likely reached the expected endpoint. STEP-1 nadir was week 60; STEP-4 plateaued weeks 60–68. [1, 2] Shift the goal from losing to holding. This is success, not stagnation.
⚠️ Important

Do not increase your dose, skip doses, stop treatment, or combine semaglutide with another GLP-1 in response to a plateau. Dose decisions belong with your prescriber. [8]

Is a Plateau a Sign the Medication Has Stopped Working?

⚡ Direct Answer

Usually not. Semaglutide rarely stops working abruptly. During a plateau it typically continues to reduce appetite, control cravings, improve portion sizes and support blood-sugar regulation — all of which are actively holding your weight down. Withdrawal trials confirm this: when semaglutide is removed, weight climbs back. Its ongoing effect is what is keeping the scale where it is.

The STEP-1 trial extension is the clearest evidence on this point. One year after stopping semaglutide, participants had regained roughly two-thirds of the weight they had lost, and the cardiometabolic improvements they had gained reverted toward baseline. If the drug had truly "stopped working" during a plateau, removing it would change nothing. It changes a great deal. [5]

💡 Key Principle

A flat scale on treatment usually means the medication is working hard — not that it has quit. Obesity behaves as a chronic, relapsing condition: like hypertension, it responds to ongoing treatment rather than being cured by a course of it.

What Should You Do About a Plateau?

⚡ Direct Answer

Work through three stages: first confirm the plateau is real by tracking waist and body composition rather than scale weight alone; second, protect muscle with adequate protein and resistance training while recalculating your calorie needs at your current weight; third, if nothing moves after two to three months on a maintenance dose, book a medical review rather than self-adjusting your dose.

1
Confirm it's actually a plateau
Weigh weekly, not daily, and judge the trend over 4–6 weeks. Then check what the scale can't see: waist circumference, how clothes fit, progress photos, strength gains. A flat scale with a shrinking waist is not a plateau — it is recomposition. [4]
Track waistBody composition →
2
Protect muscle, then reopen the deficit
Hit 1.6–2.2 g of protein per kg body weight per day and add resistance training 2–3× weekly — this is the highest-leverage change available to you, because it defends the metabolic rate the plateau is eating. Then recalculate your calorie needs at your current weight and close the gap modestly. Do not slash calories — severe restriction accelerates muscle loss and makes the plateau worse. [7]
Protein firstLift 2–3×/weekRecalculate TDEE
3
If nothing moves in 2–3 months — get reviewed
A prolonged plateau on a maintenance dose warrants a proper clinical assessment: dose stage, protein intake, training, sleep, stress, current medications, and screening for hypothyroidism, PCOS or insulin resistance. In many cases the barrier is identifiable and fixable without changing the medication at all. [9]
Never self-escalateRule out thyroid / PCOS

If resistance training is not yet part of your week, start here: how to start exercising when you're out of shape. No gym required — bodyweight progressions and bands provide the muscle-preserving signal.

Plateaued for more than two months?

A prolonged plateau doesn't always mean you need a different medication — it usually means your plan needs refining. Karespot's Internal Medicine specialists and Endocrinologists review dose, nutrition, protein, training, sleep and metabolic health, and screen for the conditions that quietly blunt progress.

Check Your Eligibility → Explore more guides on Kare Hub →

Frequently Asked Questions

Is it normal to stop losing weight on semaglutide?
Yes. Plateaus are a normal, expected part of treatment. In STEP-1, weight loss reached its nadir at week 60; in STEP-4 it plateaued between weeks 60 and 68 even on continued semaglutide. Metabolic adaptation means a lighter body needs fewer calories, which naturally slows further loss. [1, 2]
Why does a weight-loss plateau happen on semaglutide?
Your energy balance re-equalises. As you lose weight your body needs fewer calories to function, you may lose metabolically active muscle alongside fat, and small increases in intake or drops in activity accumulate. Together these erode the calorie deficit that produced your earlier results — even though nothing about your behaviour has changed. [3]
How long does a semaglutide plateau last?
There is no fixed duration. A stall of two to four weeks is routine and usually resolves on its own. If your weight has been completely flat for more than eight to twelve weeks on the 2.4 mg maintenance dose despite consistent habits, book a medical review — a modifiable cause can often be identified. [4]
Can semaglutide stop working over time?
Semaglutide does not typically stop working suddenly. A stall is more likely due to metabolic adaptation, loss of lean muscle, changes in calorie intake or activity, or other health factors. Withdrawal studies show the drug is still exerting a real effect during a plateau — removing it causes weight to climb back. [5]
Does semaglutide cause muscle loss?
Some lean mass loss occurs with any substantial weight loss, and in GLP-1 trials lean soft tissue has accounted for roughly 26–40% of total weight lost. It is largely modifiable: protein of 1.6–2.2 g/kg/day plus resistance training 2–3× weekly is consistently associated with preserving lean tissue. Set your target with the Karespot Protein Calculator. [3, 7]
Should I increase my semaglutide dose if I've plateaued?
Not on your own, and not automatically. A plateau alone is not an indication for escalation. Your doctor will first look for modifiable causes — protein intake, strength training, sleep, stress, adherence and underlying conditions — before considering a dose change. [8]
Should I stop semaglutide if I've stopped losing weight?
This is the one thing the evidence most strongly advises against. In the STEP-1 trial extension, participants regained approximately two-thirds of their lost weight within a year of stopping, and cardiometabolic gains reverted toward baseline. A stable weight on treatment usually means the medication is actively holding your weight down. Discuss any change with your prescriber. [5]
Is a plateau at week 10 the same as a plateau at month 14?
No — they are completely different situations. A plateau early in treatment usually means you have not yet reached a therapeutic dose, since semaglutide is titrated over 16 weeks to 2.4 mg. A plateau after 12–15 months on a maintenance dose is more likely the expected trial-observed endpoint: your body arriving at a new set point. The first calls for patience; the second calls for a shift from losing to holding. [1, 8]
Can I lose fat even if the scale isn't moving?
Yes. Water retention, hormonal shifts and simultaneous muscle gain can all mask fat loss. Waist circumference, how your clothes fit, progress photos and body composition measurement often reveal progress the scale cannot capture. For Asian Indians, abdominal obesity is defined at a waist circumference above 90 cm in men and 80 cm in women. [9]
📚 Sources & Citations
All citations are numbered sequentially and hyperlinked to source. Peer-reviewed literature, regulatory labelling and clinical guidelines only.
1

Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.

doi.org/10.1056/NEJMoa2032183
2

Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. 2021;325(14):1414–1425.

doi.org/10.1001/jama.2021.3224
3

GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity: a systematic review and meta-analysis. Int J Obes. 2026.

doi.org/10.1038/s41366-026-02088-1
4

Mayo Clinic. Getting Past a Weight-Loss Plateau. Mayo Foundation for Medical Education and Research; 2024.

mayoclinic.org — Weight-Loss Plateau
5

Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–1564.

doi.org/10.1111/dom.14725
6

Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: a case series. Transl J ACSM. 2025.

pmc.ncbi.nlm.nih.gov — Lean Soft Tissue Preservation
7

Leidy HJ, Clifton PM, Astrup A, et al. The Role of Protein in Weight Loss and Maintenance. Am J Clin Nutr. 2015;101(6):1320S–1329S.

doi.org/10.3945/ajcn.114.084038
8

Novo Nordisk. WEGOVY (semaglutide) injection — Prescribing Information. US Food and Drug Administration. 2023.

accessdata.fda.gov — Wegovy Prescribing Information
9

Endocrine Society of India. ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India — An Update. Indian J Endocrinol Metab. 2025;29(4):355–365.

doi.org/10.4103/ijem.ijem_680_25
Karespot Resources
K1

Karespot. GLP-1 Support Programme — Holistic Weight Management.

karespot.in/products/glp-1-support-program
K2

Karespot. Understanding Macronutrients: What's the Best Macro Ratio for Weight Loss on GLP-1? Kare Hub Blog, Jun 2026.

karespot.in — Macro Ratio Guide
K3

Karespot. How to Calculate Your BMR and Use It for Weight Loss. Kare Hub Blog, 2026.

karespot.in — BMR Guide
K4

Karespot. How to Start Exercising When You're Out of Shape. Kare Hub Blog, Jun 2026.

karespot.in — Exercise Guide
K5

Karespot. Free Protein Calculator.

karespot.in/pages/protein-calculator
K6

Karespot. Free Body Composition Calculator.

karespot.in/pages/body-composition-calculator
Last reviewed: July 2026 · If you spot an outdated link, please contact our team.
About the Authors
PG
Dr. Prakrati Garg
Research Associate, Shoolini University · Content Strategist, Karespot

Dr. Prakrati Garg is a Research Associate and published researcher in Biotechnology at Shoolini University, and Content Strategist at Karespot. With expertise in herbal drug development, nanotechnology, and drug delivery systems, she brings a rigorous scientific approach to Karespot's health and wellness content.

Research AssociateShoolini UniversityPhD BiotechnologyDrug Delivery SystemsPublished Researcher
Written: July 2026 · ResearchGate: researchgate.net/profile/Prakrati-Garg
SU
Dr. Sana Umar
Assistant Professor, Doon Medical College · FRCP · NMC Registered · Medical Reviewer, Karespot

Dr. Sana Umar is an Assistant Professor at Doon Medical College and Medical Reviewer at Karespot. A Clinical Pathologist with FRCP credentials and NMC registration (UKMC Reg. 8506), she ensures all clinical content aligns with current prescribing guidelines and evidence-based best practices in GLP-1 therapy and weight management medicine.

Assistant ProfessorDoon Medical CollegeClinical PathologistFRCPNMC RegisteredUKMC Reg. 8506
Reviewed: July 2026 · This article is for informational purposes only and does not constitute medical advice.
About Karespot

Weight loss and lifestyle change can feel like a lonely road. At Karespot, we believe you should never have to walk it alone.

Karespot is a telehealth platform that connects patients across India with a team of MBBS + MD (Internal Medicine) specialists and Endocrinologists who provide personalised, medically supervised care. We believe that medication is a tool, not the answer alone. Real, lasting change comes from building the habits and lifestyle that carry you forward long after treatment ends.

Every Karespot patient is supported by a holistic team: a doctor who understands your metabolic health, a registered dietician who adapts your nutrition to your real life, a clinical psychologist who helps you understand your relationship with food, and a lifestyle health coach who helps you build the daily habits that last.

Delhi & NCR: New Delhi, Noida, Gurugram, Faridabad, Ghaziabad

Uttarakhand: Dehradun, Haridwar, Roorkee, Haldwani, Rudrapur, Rishikesh, Nainital, Kotdwar

Uttar Pradesh: Lucknow, Kanpur, Agra, Varanasi, Prayagraj, Meerut, Gorakhpur, Aligarh, Bareilly

Maharashtra: Mumbai, Pune, Nagpur, Nashik, Thane, Navi Mumbai, Aurangabad

Karnataka: Bengaluru, Mysuru, Mangaluru, Hubballi-Dharwad, Belagavi

Telangana: Hyderabad, Warangal, Nizamabad, Karimnagar

Punjab & Chandigarh: Amritsar, Ludhiana, Jalandhar, Patiala, Chandigarh, Mohali

Other Cities: Chennai, Kolkata, Ahmedabad, Jaipur, Surat, Kochi, Indore, Coimbatore, Bhopal, Visakhapatnam, Thiruvananthapuram

Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Semaglutide is a prescription medicine that must be prescribed and supervised by a qualified Internal Medicine specialist or Endocrinologist. Never start, stop, or adjust your dose without consulting your Karespot doctor.

All Information you need about GLP-1

Your ultimate GLP-1 guide

Discover the wide range of Karespot weight-loss offerings tailored to your needs

We don't just prescribe medicines; we combine this breakthrough metabolic medication with expert health coaching to target weight loss at both a biological and behavioural level.
Explore our offering